The Healing Company Inc.
HLCO · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $2 |
| % Growth | -7.3% | 4.7% | 34.2% | – |
| Cost of Goods Sold | $1 | $4 | $1 | $1 |
| Gross Profit | $2 | -$0 | $2 | $1 |
| % Margin | 52.4% | -12.9% | 57.2% | 37.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $6 | $3 | $4 |
| SG&A Expenses | $5 | $7 | $4 | $5 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $2 | $0 | $1 |
| Operating Expenses | $5 | $7 | $4 | $5 |
| Operating Income | -$4 | -$12 | -$2 | -$3 |
| % Margin | -116% | -352.8% | -68% | -142.2% |
| Other Income/Exp. Net | -$1 | $3 | $0 | $1 |
| Pre-Tax Income | -$4 | -$9 | -$2 | -$3 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | -$4 | -$9 | -$2 | -$3 |
| % Margin | -145% | -265% | -68% | -127.4% |
| EPS | -0.078 | -0.16 | -0.042 | -0.06 |
| % Growth | 51.2% | -280% | 29.7% | – |
| EPS Diluted | -0.078 | -0.16 | -0.042 | -0.06 |
| Weighted Avg Shares Out | 57 | 54 | 51 | 50 |
| Weighted Avg Shares Out Dil | 57 | 54 | 51 | 50 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$9 | -$2 | -$3 |
| % Margin | -137.5% | -262.7% | -59.4% | -109.9% |